FDA Inspection
Eagle Pharma Outsourcing LLCEagle Pharma Outsourcing LLC – FDA Inspection, Feb 27, 2025
Record Details
This FDA Inspection record concerns Eagle Pharma Outsourcing LLC, with an inspection on February 27, 2025, issued by the New Orleans District Office, covering human drugs.
View Company Profile
ID · 80b99a47-cb5e-4f94-a3fc-f5fff43c4070
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1262160
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.28(a)Protective Apparel Not Worn
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Eagle Pharma Outsourcing LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 5, 2026 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
| August 12, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 18, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 21, 2015 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Eagle Pharma Outsourcing LLC
- FDA Inspection 1306298 - 2026-03-05
- FDA Inspection 1149844 - 2021-08-12
- FDA Inspection 1053615 - 2018-05-18
- FDA Inspection 942734 - 2015-08-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.